Santen Pharmaceutical Co Ltd
TSE:4536

Watchlist Manager
Santen Pharmaceutical Co Ltd Logo
Santen Pharmaceutical Co Ltd
TSE:4536
Watchlist
Price: 1 670.5 JPY 0.39% Market Closed
Market Cap: 606.7B JPY
Have any thoughts about
Santen Pharmaceutical Co Ltd?
Write Note
Santen Pharmaceutical Co Ltd
/
Cash Flow Statement
/
Net Change in Cash

Santen Pharmaceutical Co Ltd
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Santen Pharmaceutical Co Ltd
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Santen Pharmaceutical Co Ltd
TSE:4536
Net Change in Cash
¥44.2B
CAGR 3-Years
N/A
CAGR 5-Years
34%
CAGR 10-Years
0%
Takeda Pharmaceutical Co Ltd
TSE:4502
Net Change in Cash
¥541B
CAGR 3-Years
N/A
CAGR 5-Years
19%
CAGR 10-Years
N/A
Daiichi Sankyo Co Ltd
TSE:4568
Net Change in Cash
¥116.9B
CAGR 3-Years
6%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Otsuka Holdings Co Ltd
TSE:4578
Net Change in Cash
-¥3.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Chugai Pharmaceutical Co Ltd
TSE:4519
Net Change in Cash
¥236.5B
CAGR 3-Years
189%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Astellas Pharma Inc
TSE:4503
Net Change in Cash
-¥258.6B
CAGR 3-Years
N/A
CAGR 5-Years
-39%
CAGR 10-Years
N/A
No Stocks Found

Santen Pharmaceutical Co Ltd
Glance View

Market Cap
594.1B JPY
Industry
Pharmaceuticals

Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. The company is headquartered in Osaka, Osaka-Fu and currently employs 4,229 full-time employees. The firm has medical pharmaceutical business, OTC drugs business, medical devices business and other businesses. The firm engages in manufacture, sale and clinical development of medical pharmaceutical products, the development, manufacturing and sales of medical equipment, as well as the cleaning business. The firm operates in Japan, Europe, Asia, North America markets.

Intrinsic Value
2 142.23 JPY
Undervaluation 22%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Santen Pharmaceutical Co Ltd's Net Change in Cash?
Net Change in Cash
44.2B JPY

Based on the financial report for Jun 30, 2024, Santen Pharmaceutical Co Ltd's Net Change in Cash amounts to 44.2B JPY.

What is Santen Pharmaceutical Co Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
0%

Back to Top
ALPHA SPREAD
Follow us
Join more than 201,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.